Navigation Links
MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Date:3/11/2008

Thursday, March 13, 2008 - 11:00 a.m. ET; 8:00 a.m. PT

VANCOUVER and SAN DIEGO, March 11 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, will host a conference call and webcast on Thursday, March 13, 2008 at 11:00 a.m. ET (8:00 a.m. PT) to discuss financial results for the third fiscal quarter ended January 31, 2008 and provide an update on company activities. To participate in the conference call, please dial 416-644-3417 or 1-800-732-0232. The call will be available for replay until March 27, 2008 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21263848 followed by the number sign. The live and archived webcast can be accessed through the company's website at http://www.migenix.com for the next 90 days.

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's programs include drug candidates for: the prevention of catheter-related infections (Phase III), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of dermatological diseases (end of Phase II), the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis B infections (preclinical). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at http://www.migenix.com.

"Jim DeMesa"

James M. DeMesa, M.D.

President & CEO

CONTACT: Art Ayres, MIGENIX Inc., Tel: (604) 221-9666, Ext. 233, aayres@migenix.com; Dian Griesel, Ph.D., Investor Relations Group, Tel: (212) 825-3210, Theproteam@aol.com


'/>"/>
SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. MIGENIX releases CEO message #22
2. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
3. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
4. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
5. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
7. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
8. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
9. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. NeoStem to Present at Third Annual Stem Cell Summit in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008).... 15 /- SuperGen, Inc.,(Nas...o the discovery and,development of novel cancer th...esent five posters at the 20th EORTC-NCI-AACR Symp...s" on October 23 and 24, 2008., SuperGen,s presen...nces,in the following compounds: MP-470, SGI-1776 ...
(Date:10/15/2008)...RNewswire-FirstCall/ - GeneNews Limited (TSX: GEN)...arker tests for the early,detection of diseases an...that it has appointed Patrick Terry as its lead st...ColonSentry(TM), the world,s fist blood-based,test...al cancer. Mr. Terry,is one of the co-founders of ...
(Date:10/15/2008).... 15 /- The increased emphasis on,saf...re costly medical,product development programs and...sive actions by Sponsors to respond appropriately....und in consulting organizations. GZP,has already e...ance errors,that can lead to adverse regulatory ac...
(Date:10/14/2008)...ctober 2008] Recent research from the Swedish medi...etely new properties of the skin,s stem cells dis...udies, which are published in Nature Genetics, s...cells can divide actively and transport themselves...n,t behave at all in the way we,d previously thoug...
Breaking Biology Technology:SuperGen to Present Data at EORTC-NCI-AACR 2GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM) 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 3
... ,Study protein function more efficiently with s...Heidi Davis David T. Wong ,Kelly Wynne Vilma N...Sorge Edward Marsh ,Stratagene , Spencer Stev..., Stratagene now offers sequence-validated and ex...ression vector. These clones eliminate the time sp...
..., Miniprep and midiprep quantities of pure high-...tagene , The StrataPrep plasmid miniprep and m...d 350 g, respectively, of high-purity plasmid,DN... easily purify very,large plasmids, including co...tion, a SuperCos I clone containing a 40-kb , ...
..., Novel pdual expression vector for high-level e... , Kerstien A. Padgett Joseph A. Sorge ,St...pression vector,* which permits,high-level expre... prokaryotic,systems. The vector contains the pr...lovirus (CMV) immediate early gene for constitutiv...
..., Investigating programmed cell death , We...,Pingerelli ,Stratagene , The apoptotic respo...the,regulation of a variety of genes that intera...llular stimuli. Stratagene is introducing RT-PCR p...ed in inducing and regulating the,apoptotic resp...
Other Biology Technology:Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 2Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 3Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 4Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 5Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 6Easy Cosmid DNA Purification with StrataPrep Kits 2Mammalian and Bacterial Expression in One Vector 2Mammalian and Bacterial Expression in One Vector 3Mammalian and Bacterial Expression in One Vector 4Mammalian and Bacterial Expression in One Vector 5Mammalian and Bacterial Expression in One Vector 6RT-PCR Primers for the Study of Apoptosis 2RT-PCR Primers for the Study of Apoptosis 3RT-PCR Primers for the Study of Apoptosis 4RT-PCR Primers for the Study of Apoptosis 5RT-PCR Primers for the Study of Apoptosis 6RT-PCR Primers for the Study of Apoptosis 7
(Date:10/15/2008)...enter (SDSC) at the University of California, San ...called the Triton Resource, a high-impact, massive...rate innovation, collaboration, and discovery thro...ucture at SDSC. , SDSC is leading the effort to ... and UC San Diego researchers. Specific details o...
(Date:10/15/2008)... during its embryonic/fetal development, it can re... functional by birth, provided some of the heart c...the Max Delbrck Center for Molecular Medicine (MDC...lleagues from Australia. They were able to demonst...heart divide more frequently and thus displace the...
(Date:10/14/2008)...the University of Idaho currently are involved in ... been running rampant for the past decade. But the...nted list. Instead, it,s on the minds of ecologist... Batrachochytrium dendrobatidis (Bd). It is a "c...otein found in the skin of amphibians, and is part...
(Date:10/14/2008)...n the last decade, biomedical and research breakth...elped transform the care of children, improving di...v. 8 and 9, Morgan Stanley Children,s Hospital of ...al Center will host a conference at the Grand Hyat...ine," to exchange the latest advances in genetics,...
Breaking Biology News(10 mins):San Diego Supercomputer Center and UCSD announce 'Triton Resource' 2San Diego Supercomputer Center and UCSD announce 'Triton Resource' 3San Diego Supercomputer Center and UCSD announce 'Triton Resource' 4Repair in the developing heart 2Modern genetics vs. ancient frog-killing fungus 2Modern genetics vs. ancient frog-killing fungus 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 2Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 4AUDIO from Medialink and Kelloggs 3A A Healthy Beginning Every Day 12818 1Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 1Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 2Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 3Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 1Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 2Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 3Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 4Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 5Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 6Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 7Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 8Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 9Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 10Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 11Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 12Study Finds Variations in Doses of Radiation Therapy 12812 1Study Finds Variations in Doses of Radiation Therapy 12812 2Study Finds Variations in Doses of Radiation Therapy 12812 3
...ringe at the idea, but sperm-producing stem cells ...e lab, and frozen for future use. A team in the Ne...l stem cells from cows and cultured them inside mo...be done for men. "This is a very promising route t...py," Dirk de Rooij of Utrecht University, Netherla...
...mental tuberculosis drug may be effective against ... but could also be the first compound to treat the...eport their results today at the 2006 ASM Biodefen...ompound is the lead has a very different mechanism...reat tuberculosis. We have identified no cross re...
...ones are not associated with an increased risk of ...rst UK study of the relationship between mobile ph...hed online by the BMJ today. , The four year study...hester and the Institute of Cancer Research, Londo...e were not at a greater overall risk of developing...
... seem bigger than life ?big bones, big mysteries. ...s about dinosaurs may come from small ?very small ...chigan State University zoologist Peggy Ostrom. "W...ls, and proteins can tell us about diseases, about...what they ate and who they are related to." , Ost...
Other Biology News:Testes to incubate stem cells 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2Mobile phone use not linked to increased risk of glioma brain tumours 2Next good dinosaur news likely to come from small packages 2
...al Stem Cell Functional Identification Kit contain...n be used for the short-term maintenance, differen...f NSCs into astrocyte, neuron and oligodendrocyte ...ti-human Nestin, mouse anti-human Glial Fibrillary...
Anti-Mouse MIP-1g, Biotin (Polyclonal) (rabbit IgG)
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
Request Info
Biology Products: